Explore News
-
70% of Patients Achieve Weight Loss with Semaglutide Post-Surgery
New research reveals that semaglutide, a GLP-1 receptor agonist, significantly aids weight loss in patients…
-
Vegan Diet Surges Ahead in Health and Emissions Trial
A randomized clinical trial shows plant-based eating significantly improves metabolic markers and slashes carbon footpri
-
Non-THC Cannabis Compound Tied to Weight Loss in New Study
A groundbreaking study identifies cannabigerol (CBG) as a potent regulator of appetite and metabolism, challenging…
-
Cannabis Oil Surges as Key to Weight Loss in Obese Mice
A groundbreaking UC Riverside study reveals that cannabis oil significantly reduces body weight and improves…
-
How the American Diet Is Fueling a Silent Liver Epidemic
Non-alcoholic fatty liver disease is quietly spreading across the U.S., affecting over 100 million people,…
-
Next-Gen GLP-1 Drug Survodutide Shows 16% More Weight Loss Than Zepbound
A phase 3 trial reveals survodutide, a dual GLP-1 and glucagon receptor agonist, led to…
-
New GLP-1 Drug Shows Promise for Weight Loss
A new weight loss drug has shown promising results in a phase 3 clinical trial
-
New Study Reveals Oral Microbiome’s Role in Disease Prevention
Groundbreaking research explores the oral microbiome’s impact on metabolic health
